In recognition of International Human Papillomavirus (HPV) Awareness Day, the Center for Disease Prevention and Control (SPKC) of Latvia has announced an expansion of the free vaccination program against HPV. The vaccine is recognized as the most effective method for preventing health risks associated with the virus, which can lead to various dangerous cancers including cervical, penile, oral, and oropharyngeal cancers. HPV is a prevalent virus, with up to 80% of sexually active individuals being infected at some point in their lives, often without any symptoms.

Previously, the state-funded vaccination was primarily available to girls and boys aged 12 to 17 years, who continue to be the priority group. However, the SPKC has indicated that, depending on vaccine availability, free vaccination will also be offered to individuals at high risk for HPV-related conditions. This change highlights a proactive approach to public health, aiming to reduce cancer risks associated with HPV by making the vaccine more accessible to a broader population.

High-risk individuals identified include women aged 18 to 55 years with cervical adenocarcinoma in situ (AIS) and those who have undergone cervical screening. This initiative not only raises awareness about the dangers posed by HPV but also emphasizes the importance of vaccination in combating related health issues. By expanding access to the vaccine, Latvia aims to improve health outcomes and reduce the incidence of HPV-related cancers in the population.